Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Short-Term Noncryopreserved Hematopoietic Stem Cells: Single Center Experience of Autologous Transplantation

Sergei Voloshin, MD PhD, Andrey Garifullin, MD, Anastasiya Kuzyaeva, Vasily Shuvaev, MD, Alexander Schmidt, Alexey Kuvshinov, MD, Valentina Balashova, Zhanna Chubukina, Elena Belyakova, MD, Georgiy Rysev, MD, Alexander Chechetkin, Viktor Rugal'

Blood (2019) 134 (Supplement_1): 5636.

https://doi.org/10.1182/blood-2019-131695

Published: 2019

Journal Articles

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Mary Mansour Riwes, DO, Alexander Schmidt, Thomas Braun, John M. Magenau, MD, Attaphol Pawarode, Brian Parkin, Sarah Anand, MD, Monalisa Ghosh, John Maciejewski, Darren King, Muneesh Tewari, Sung W. Choi, Gregory A. Yanik, Kristi Maccready, Thomas Schmidt, Pavan Reddy

Blood (2019) 134 (Supplement_1): 3276.

https://doi.org/10.1182/blood-2019-131216

Published: 2019

Journal Articles

Influence of Minimal Residual Disease on Survival of Patients with Mantle Cell Lymphoma

Mariia Mikhaleva, MD, Alexey Kuvshinov, MD PhD, Alexander Schmidt, Vasily Shuvaev, MD, Karina Krutikova, MD, Elena Belyakova, Irina Martynkevich, MD PhD, Alexander Chechetkin, Sergei Voloshin, MD PhD

Blood (2018) 132 (Supplement 1): 1611.

https://doi.org/10.1182/blood-2018-99-119761

Published: 2018

Journal Articles

The Significance of Flow Cytometry and Positron Emission Tomography and Computed Tomography (PET-CT) in the Assessment of the Minimum Residual Disease in Patients with Multiple Myeloma

Andrey Garifullin, Sergei Voloshin, MD PhD, Alexey Kuvshinov, MD, Alexander Schmidt, Vasily Shuvaev, MD PhD, Yuriy Kryvolapov, Elena Belyakova, Evgeniy Krasnikov, Alexander Chechetkin

Blood (2017) 130 (Supplement 1): 3097.

https://doi.org/10.1182/blood.V130.Suppl_1.3097.3097

Published: 2017

Journal Articles

The Impact of Genetic Abnormalities (GA) and Other Factors on Survival in Patients after 65 Years with Multiple Myeloma (MM)

Andrei Garifullin, Irina Martynkevich, MD PhD, Sergei Voloshin, Alexei Kuvshinov, Ludmila Martynenko, Elizaveta Kleina, Galina Salogub, Elena Karyagina, Alexander Schmidt, Kudrat Abdulkadyrov

Blood (2015) 126 (23): 5314.

https://doi.org/10.1182/blood.V126.23.5314.5314

Published: 2015

Journal Articles

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma: Effects of Subcutaneous Injection Site and Concentration, and Patient Characteristics

Philippe Moreau, MD, Ievgenii I Karamanesht, MD, Natalia Domnikova, Maryna Y Kyselyova, MD, Kateryna Vilchevska, Vadim A Doronin, MD, PhD, Alexander Schmidt, MD, Cyrille Hulin, MD, Xavier Leleu, MD, PhD, Dixie-Lee Esseltine, MD, FRCPC, Karthik Venkatakrishnan, Donna M Skee, BS, Huaibao Feng, PhD, Suzette Girgis, Andrew Z Cakana, MD, FRCPath, William M Deraedt, PhD, Thierry Facon, MD

Blood (2011) 118 (21): 1863.

https://doi.org/10.1182/blood.V118.21.1863.1863

Published: 2011

Journal Articles

Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells

Andreas Hofmann, Bertran Gerrits, Alexander Schmidt, Thomas Bock, Damaris Bausch-Fluck, Rudolf Aebersold, Bernd Wollscheid

Blood (2010) 116 (13): e26–e34.

https://doi.org/10.1182/blood-2010-02-271270

Published: 2010

Includes: Supplemental data

Journal Articles

Second Stem Cell Harvest from Unrelated Donors for Patients with Relapse or Graft Failure after First Transplantation: Patient Age >50 Years and Relapse of Malignant Disease Are Associated with Poor Outcome.

Uwe Platzbecker, Susanne Zapf, Cathrin Theuser, Alexander Schmidt, Claudia Rutt, Gerhard Ehninger, Martin Bornhauser

Blood (2006) 108 (11): 3107.

https://doi.org/10.1182/blood.V108.11.3107.3107

Published: 2006

Journal Articles

Long-Term Follow-Up of 5,930 Unrelated Volunteers Donating Bone Marrow or Peripheral Blood Stem Cells.

Gerhard Ehninger, Gabi Rall, Frank Kroschinsky, Ulrich S. Schuler, Alexander Schmidt, Kristina Hoelig, Martin Bornhaeuser, Claudia Rutt

Blood (2004) 104 (11): 2754.

https://doi.org/10.1182/blood.V104.11.2754.2754

Published: 2004

NARROW

Short-Term Noncryopreserved Hematopoietic Stem Cells: Single Center Experience of Autologous Transplantation

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Influence of Minimal Residual Disease on Survival of Patients with Mantle Cell Lymphoma

The Significance of Flow Cytometry and Positron Emission Tomography and Computed Tomography (PET-CT) in the Assessment of the Minimum Residual Disease in Patients with Multiple Myeloma

The Impact of Genetic Abnormalities (GA) and Other Factors on Survival in Patients after 65 Years with Multiple Myeloma (MM)

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma: Effects of Subcutaneous Injection Site and Concentration, and Patient Characteristics

Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells

Second Stem Cell Harvest from Unrelated Donors for Patients with Relapse or Graft Failure after First Transplantation: Patient Age >50 Years and Relapse of Malignant Disease Are Associated with Poor Outcome.

Long-Term Follow-Up of 5,930 Unrelated Volunteers Donating Bone Marrow or Peripheral Blood Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only